Request that the FDA issue appropriate labeling and risk communication requirements for systemic fluoroquinolone antibiotics
🏛 Food and Drug Administration (FDA)FDA-2026-P-5116
Documents
1
Total comments
5
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document